Citations

Showing 10 of 108094 citations.

SIRT6 promotes mitochondrial fission and subsequent cellular invasion in ovarian cancer
Bandopadhyay, Shreya, Prasad, Parash , Ray, Upasana , Ghosh, Damayanti Das , Roy, Sib Sankar

Mayo Clinic

FEBS Open Bio | June 10, 2022 | Volume: 12 | Issue: 9 | Pages: 1657-1676

10.1002/2211-5463.13452 | PMID 35686673 Get It

Ovarian cancer ranks fifth in terms of cancer mortality in women due to lack of early diagnosis and poor clinical management. Characteristics like high cellular proliferation, EMT and metabolic alterations contribute to oncogenicity. Cancer, being a “metabolic disorder,” is governed by various key regulatory factors like metabolic enzymes, oncogenes, and tumor suppressors. Sirtuins (SIRT1‐SIRT7) belong to the group of NAD + deacetylase and ADP‐ribosylation enzymes that function as NAD + sensors and metabolic regulators. Among sirtuin orthologs, SIRT6 emerges as an important oncogenic player, although its possible mechanistic involvement in ovarian cancer advancement is still elusive. Our data indicated a higher expression of SIRT6 in ovarian cancer tissues compared with the non‐malignant ovarian tissue. Further, we observed that overexpression of SIRT6 enhances glycolysis and oxidative phosphorylation in ovarian cancer cells. The energy derived from these processes facilitates migration and invasion through invadopodia formation by reorganization of actin fibers. Mechanistically, SIRT6 has been shown to promote ERK1/2‐driven activatory phosphorylation of DRP1 at serine‐616, which has an obligatory role in inducing mitochondrial fission. These fragmented mitochondria facilitate cell movement important for metastases. siRNA‐mediated downregulation of SIRT6 was found to decrease cellular invasion through compromised mitochondrial fragmentation and subsequent reduction in stress fiber formation in ovarian cancer cells. Thus, the present report establishes the impact of SIRT6 in the regulation of morphological and functional aspects of mitochondria that modulates invasion in ovarian cancer cells.
Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest
Ivancich, Marko, Lutwick, Larry I., Lutwick, Larry, Shweta, Fnu

Mayo Clinic

American Journal of Case Reports | June 10, 2022 | Volume: 23 | Issue: No issue available | Pages: No page available

10.12659/ajcr.936326 | PMID 35844076 Get It

Use of peripherally inserted central catheters with a dedicated vascular access specialists team versus centrally inserted central catheters in the management of septic shock patients in the ICU
Raza, Hassan , Nokes, Brandon , Concejo, Bruno Álvarez , Colquist, Julie , Patel, B. M. , Cartin‐Ceba, Rodrigo , Nokes, Brandon T , Park, John , Patel, Bhavesh M , Park, John, Kashyap, Rahul

Mayo Clinic

The Journal of Vascular Access | June 10, 2022 | Volume: 25 | Issue: 1 | Pages: 218-224

10.1177/11297298221105323 | PMID 35686502 Get It

Objectives: Peripherally inserted central catheters (PICCs) are increasingly recognized as an alternative to centrally inserted central catheters (CICCs) in critical care, yet the data regarding the safety and feasibility of this choice in septic shock management is growing but still lacking. In this study, we aimed to determine the feasibility, safety, and impact on outcomes of using dedicated vascular access specialist (VAS) teams to insert PICCs versus CICCs on patients admitted to the ICU with septic shock. Design: Retrospective cohort study. Setting: Mayo Clinic Rochester Medical ICU and Mayo Clinic Arizona Multidisciplinary ICU from 2013 to 2016. Patients: All adult patients hospitalized with diagnosis of septic shock excluding patients who declined authorization for review of their medical records, mixed shock states, and readmissions. Interventions: None. Measurement and main results: Comprehensive data regarding septic shock diagnosis and resuscitation were abstracted from electronic medical records. A total of 562 patients with septic shock were included in the study; 215 patients were resuscitated utilizing a PICC and 347 were resuscitated using a CICC. On univariate analysis, the time to central line insertion and time to vasopressor initiation were found to be reduced in those who received PICC at time of ICU admission versus CICC. Other favorable outcomes were also observed in those who received PICC versus CICC including shorter ICU length of stay and lower unadjusted hospital mortality. A multivariable analysis for hospital mortality showed that after adjusting for important covariates, neither the time to central line insertion nor the time to vasopressor initiation was associated with a lower hospital mortality. Conclusions: Across two tertiary referral centers within the same enterprise, use of a dedicated VAS team for insertion of PICCs for initial resuscitation in patients with septic shock was feasible and associated with shorter time to central venous access and initiation of vasopressors; however, adjusted hospital mortality was not different between the two groups.
Adherence to the AICR Cancer Prevention Recommendations and Subsequent Morbidity and Mortality in the Iowa Women's Health Study Cohort
Gilmore, Julie M. Eichenberger, Kushi, Larry H., Lazovich, DeAnn, Anderson, Kristin E. , Sellers, Thomas A. , Folsom, Aaron R. , Cerhan, James R. , Potter, John D. , Janney, Carol A. , Kushi, Larry H.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 10, 2022 | Volume: 13 | Issue: 7 | Pages: 1114-1120

10.1158/1055-9965.1114.13.7 Get It

Abstract In 1997, the American Institute for Cancer Research (AICR) published 14 recommendations related to diet for individuals to reduce cancer incidence on a global basis; smoking was also discouraged. We operationalized these into nine recommendations that are particularly relevant to western populations in a cohort of 29,564 women ages 55 to 69 years at baseline in 1986 who had no history of cancer or heart disease. The cohort was followed through 1998 for cancer incidence (n = 4,379), cancer mortality (n = 1,434), cardiovascular disease (CVD) mortality (n = 1,124), and total mortality (n = 3,398). The median number (range) of recommendations followed was 4 (0-8), and 33% of the cohort had ever smoked. Women who followed no or one recommendation compared with six to nine recommendations were at an increased risk of cancer incidence [relative risk (RR) 1.35, 95% confidence interval (CI) 1.15-1.58] and cancer mortality (RR 1.43, 95% CI 1.11-1.85), but there was no association with CVD mortality (RR 1.06, 95% CI 0.78-1.43). We calculated the population attributable risk (PAR) to estimate the proportion of cancer incidence, cancer mortality, and CVD mortality that theoretically would have been avoidable if the entire cohort had never smoked, had followed six to nine recommendations, or had done both. The PARs for smoking were 11% (95% CI 10-13) for cancer incidence, 21% (95% CI 17-24) for cancer mortality, and 20% (95% CI 16-23) for CVD mortality. The PARs for not following six to nine recommendations were 22% (95% CI 12-30) for cancer incidence, 11% (95% CI −5 to 24) for cancer mortality, and 4% (95% CI −20 to 19) for CVD mortality. When smoking and the operationalized AICR recommendations were combined together, the PARs were 31% (95% CI 19-37) for cancer incidence, 30% (95% CI 15-40) for cancer mortality, and 22% (95% CI 4-36) for CVD mortality. These data suggest that the adherence to the AICR recommendations, independently and in conjunction with not smoking, is likely to have a substantial public health impact on reducing cancer incidence and, to a lesser degree, cancer mortality at the population level.
Machine Learning Consensus Clustering of Morbidly Obese Kidney Transplant Recipients in the United States
Jadlowiec, Caroline C. , Mao, Michael A. , Leeaphorn, Napat , Kaewput, Wisit , Vaitla, Pradeep , Pattharanitima, Pattharawin , Tangpanithandee, Supawit , Krisanapan, Pajaree , Cooper, Matthew , Cheungpasitporn, Wisit , Jadlowiec, Caroline , Mao, Michael A , Kaewput, Wisit , Pattharanitima, Pattharawin , Tangpanithandee, Supawit , Krisanapan, Pajaree , Cheungpasitporn, Wisit , Cooper, Matthew , Thongprayoon, Charat , Mao, Shennen A. , Qureshi, Fawad , Nissaisorakarn, Pitchaphon

Mayo Clinic

Journal of Clinical Medicine | June 10, 2022 | Volume: 11 | Issue: 12 | Pages: 3288

10.3390/jcm11123288 | PMID 35743357 Get It

Background: This study aimed to better characterize morbidly obese kidney transplant recipients, their clinical characteristics, and outcomes by using an unsupervised machine learning approach. Methods: Consensus cluster analysis was applied to OPTN/UNOS data from 2010 to 2019 based on recipient, donor, and transplant characteristics in kidney transplant recipients with a pre-transplant BMI ≥ 40 kg/m2. Key cluster characteristics were identified using the standardized mean difference. Post-transplant outcomes, including death-censored graft failure, patient death, and acute allograft rejection, were compared among the clusters. Results: Consensus clustering analysis identified 3204 kidney transplant recipients with a BMI ≥ 40 kg/m2. In this cohort, five clinically distinct clusters were identified. Cluster 1 recipients were predominantly white and non-sensitized, had a short dialysis time or were preemptive, and were more likely to receive living donor kidney transplants. Cluster 2 recipients were older and diabetic. They were likely to have been on dialysis >3 years and receive a standard KDPI deceased donor kidney. Cluster 3 recipients were young, black, and had kidney disease secondary to hypertension or glomerular disease. Cluster 3 recipients had >3 years of dialysis and received non-ECD, young, deceased donor kidney transplants with a KDPI < 85%. Cluster 4 recipients were diabetic with variable dialysis duration who either received non-ECD standard KDPI kidneys or living donor kidney transplants. Cluster 5 recipients were young retransplants that were sensitized. One-year patient survival in clusters 1, 2, 3, 4, and 5 was 98.0%, 94.4%, 98.5%, 98.7%, and 97%, and one-year death-censored graft survival was 98.1%, 93.0%, 96.1%, 98.8%, and 93.0%, respectively. Cluster 2 had the worst one-year patient survival. Clusters 2 and 5 had the worst one-year death-censored graft survival. Conclusions: With the application of unsupervised machine learning, variable post-transplant outcomes are observed among morbidly obese kidney transplant recipients. Recipients with earlier access to transplant and living donation show superior outcomes. Unexpectedly, reduced graft survival in cluster 3 recipients perhaps underscores socioeconomic access to post-transplant support and minorities being disadvantaged in access to preemptive and living donor transplants. Despite obesity-related concerns, one-year patient and graft survival were favorable in all clusters, and obesity itself should be reconsidered as a hard barrier to kidney transplantation.
Cardiac amyloidosis – An Underdiagnosed Cause of Heart Failure: A Case Report and Review of Literature
Parmar, Kanak , Sethi, Pooja , Tijani, Lukman, Hurst, Philip D., Pertuz, Gaspar Del‐Rio, Argueta‐Sosa, Erwin , Benjanuwattra, Juthipong , Pertuz, Gaspar Del Rio

Mayo Clinic

No container title available | June 10, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.165484104.46215880/v1 Get It

Restrictive cardiomyopathy secondary to cardiac amyloidosis is an underdiagnosed, but treatable, cause of heart failure involving an extracellular deposition of misfolded protein. Hereby, we report a case of female patient with heart failure and nephrotic syndrome. The case underscores the importance of a timely diagnosis.
Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services
Top, Karina A. , Chen, Robert T. , Carleton, Bruce , Creech, C. Buddy , Kochhar, Sonali , Gutu, Kimberley , Cutland, Clare , Levy, Ofer , Ozonoff, Al , Crawford, Nigel W. , Poland, Gregory A.

Mayo Clinic

Clinical Infectious Diseases | June 10, 2022 | Volume: 75 | Issue: Supplement_1 | Pages: S11-S17

10.1093/cid/ciac407 | PMID 35680552 Get It

AbstractWithin 2 years after the start of the coronavirus disease 2019 (COVID-19) pandemic, novel severe acute respiratory syndrome coronavirus 2 vaccines were developed, rigorously evaluated in large phase 3 trials, and administered to more than 5 billion individuals globally. However, adverse events of special interest (AESIs) have been described post-implementation, including myocarditis after receipt of messenger RNA (mRNA) vaccines and thrombosis with thrombocytopenia syndrome after receipt of adenoviral vector vaccines. AESIs are rare (&lt;1 to 10/100 000 vaccinees) and less frequent than COVID-19 complications, though they have associated morbidity and mortality. The diversity of COVID-19 vaccine platforms (eg, mRNA, viral vector, protein) and rates of AESIs both between and within platforms (eg, higher rate of myocarditis after mRNA-1273 vs BNT162b2 vaccines) present an important opportunity to advance vaccine safety science. The International Network of Special Immunization Services has been formed with experts in vaccine safety, systems biology, and other relevant disciplines to study cases of AESIs and matched controls to uncover the pathogenesis of rare AESIs and inform vaccine development.
Arthroscopic Posterior Capsular Release Effectively Reduces Pain and Restores Terminal Knee Extension in Cases of Recalcitrant Flexion Contracture
Reinholz, Anna K., Song, Bryant M. , Wilbur, Ryan R. , Levy, Bruce A. , Okoroha, Kelechi R. , Krych, Aaron J. , Krych, Aaron J , Camp, Christopher L.

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | June 9, 2022 | Volume: 4 | Issue: 4 | Pages: No page available

10.1016/j.asmr.2022.04.030 | PMID 36033179 Get It

Purpose To 1) evaluate the clinical efficacy of arthroscopic posterior capsular release for improving range of motion (ROM) in cases of recalcitrant flexion contracture and 2) determine patient‐reported outcomes (PROs) postoperatively. Methods Retrospective chart review was performed to identify patients who underwent arthroscopic posterior capsular release due to persistent extension deficit of the knee despite comprehensive nonoperative physical therapy between 2008 and 2021. Knee ROM and PROs (International Knee Documentation Committee [IKDC], Tegner, and visual analog scale [VAS]) were collected at final follow‐up. Results Overall, 22 patients were included with a median age of 37 years (interquartile range [IQR]: 20.5‐44.3). Of these, 8 (36%) were male and 14 (64%) were female, and average follow‐up was 3.7 ± 3.3 years. The most common etiology was knee flexion contracture after anterior cruciate ligament (ACL) reconstruction (59%). All patients failed a minimum of 3 months of nonoperative management. Prior to operative intervention, 100% of patients received physical therapy, 64% received extension knee bracing or casting, and 36% received corticosteroid injection. Median preoperative extension was 15° (IQR: 10‐25) compared to 2° (IQR: 0‐5) postoperatively ( P < .001). At final follow‐up, median extension was 0° (IQR: 0‐3.5). Postoperative VAS pain scores at rest (2 vs 0; P = .001) and with use (5 vs 1.8; P = .017) improved at final contact, and most (94%) patients reported maintaining their extension ROM. Patients with ACL‐related extension deficit reported better IKDC (81 vs 51.3; P = .008), Tegner (5.8 vs 3.6; P = .007), and VAS pain scores (rest: 0.2 vs 1.8; P = .008; use: 1.3 vs 5; P = .004) compared to other etiologies. Conclusion Arthroscopic posterior capsular release for recalcitrant flexion contracture provides an effective means for reducing pain and restoring terminal extension. The improvement in extension postoperatively was maintained for most (94%) patients at final follow‐up with a 14% reoperation rate.
Postoperative protocols following endoscopic skull base surgery: An evidence‐based review with recommendations
Abiri, Arash , Patel, Tirth , Nguyen, Emily , Tajudeen, Bobby A. , Schlosser, Rodney J. , Adappa, Nithin D. , Adappa, Nithin D. , Choby, Garret , Wang, Eric W , Kuan, Edward C , Schlosser, Rodney J , Birkenbeuel, Jack L. , Choby, Garret , Adappa, Nithin D.

Mayo Clinic

International Forum of Allergy & Rhinology | June 9, 2022 | Volume: 13 | Issue: 1 | Pages: 42-71

10.1002/alr.23041 | PMID 35678720 Get It

AbstractBackgroundPostoperative management strategies for endoscopic skull base surgery (ESBS) vary widely because of limited evidence‐based guidance.MethodsThe PubMed, EMBASE, and Cochrane databases were systematically reviewed from January 1990 through February 2022 to examine 18 postoperative considerations for ESBS. Nonhuman studies, articles written in a language other than English, and case reports were excluded. Studies were assessed for levels of evidence, and each topic's aggregate grade of evidence was evaluated.ResultsA total of 74 studies reporting on 18 postoperative practices were reviewed. Postoperative pain management, prophylactic antibiotics, and lumbar drain use had the highest grades of evidence (B). The literature currently lacks high quality evidence for a majority of the reviewed ESBS precautions. There were no relevant studies to address postoperative urinary catheter use and medical intracranial pressure reduction.ConclusionThe evidence for postoperative ESBS precautions is heterogeneous, scarce, and generally of low quality. Although this review identified the best evidence available in the literature, it suggests the urgent need for more robust evidence. Therefore, additional high‐quality studies are needed in order to devise optimal postoperative ESBS protocols.
Protocol for multicentre comparison of interictal high-frequency oscillations as a predictor of seizure freedom
Dimakopoulos, Vasileios , Gotman, Jean , Stacey, William C. , Jacobs, Julia , Papadelis, Christos , Sperling, Michael R. , Zijlmans, Maike, Imbach, Lucas, Sarnthein, Johannes , Stacey, William , Papadelis, Christos , Sarnthein, Johannes , Sperling, Michael R , Ellenrieder, Nicolás von , Cimbálník, Jan , Worrell, Gregory A. , Frauscher, Birgit

Mayo Clinic

Brain Communications | June 9, 2022 | Volume: 4 | Issue: 3 | Pages: No page available

10.1093/braincomms/fcac151 | PMID 35770134 Get It

Abstract In drug-resistant focal epilepsy, interictal high-frequency oscillations (HFOs) recorded from intracranial EEG (iEEG) may provide clinical information for delineating epileptogenic brain tissue. The iEEG electrode contacts that contain HFO are hypothesized to delineate the epileptogenic zone; their resection should then lead to postsurgical seizure freedom. We test whether our prospective definition of clinically relevant HFO is in agreement with postsurgical seizure outcome. The algorithm is fully automated and is equally applied to all data sets. The aim is to assess the reliability of the proposed detector and analysis approach. We use an automated data-independent prospective definition of clinically relevant HFO that has been validated in data from two independent epilepsy centres. In this study, we combine retrospectively collected data sets from nine independent epilepsy centres. The analysis is blinded to clinical outcome. We use iEEG recordings during NREM sleep with a minimum of 12 epochs of 5 min of NREM sleep. We automatically detect HFO in the ripple (80–250 Hz) and in the fast ripple (250–500 Hz) band. There is no manual rejection of events in this fully automated algorithm. The type of HFO that we consider clinically relevant is defined as the simultaneous occurrence of a fast ripple and a ripple. We calculate the temporal consistency of each patient’s HFO rates over several data epochs within and between nights. Patients with temporal consistency &lt;50% are excluded from further analysis. We determine whether all electrode contacts with high HFO rate are included in the resection volume and whether seizure freedom (ILAE 1) was achieved at ≥2 years follow-up. Applying a previously validated algorithm to a large cohort from several independent epilepsy centres may advance the clinical relevance and the generalizability of HFO analysis as essential next step for use of HFO in clinical practice.